Table 2.

Stage-specific estimates of prevalence of patients requiring active anti-tumour therapy for colorectal cancer in the Czech Republic in 2015 according to the eight scenarios

	Scenario 1: Constant proportion of treated patients; Constant incidence rate; Constant survival rates				Scenario 2: Constant proportion of treated patients; Constant incidence rate; Improving survival rates
Stage at diagnosis	Newly diagnosed patients	Non-terminal cancer recurrence	Terminal cancer recurrence	Total	Newly diagnosed patients	Non-terminal cancer recurrence	Terminal cancer recurrence	Total
Stage I+II	3,650	565	479	4,694	3,650	607	524	4,781
Stage III	1,783	355	541	2,679	1,783	407	625	2,815
Stage IV	1,419	181	766	2,366	1,419	212	898	2,529
Missing	220	16	99	335	220	13	76	309
All cases	7,072	1,117	1,885	10,074	7,072	1,239	2,123	10,434
	Scenario 3: Constant proportion of treated patients; Modelled incidence rate; Constant survival rates				Scenario 4: Constant proportion of treated patients; Modelled incidence rate; Improving survival rates
Stage at diagnosis	Newly diagnosed patients	Non-terminal cancer recurrence	Terminal cancer recurrence	Total	Newly diagnosed patients	Non-terminal cancer recurrence	Terminal cancer recurrence	Total
Stage I+II	3,581	547	467	4,595	3,581	589	511	4,681
Stage III	2,223	422	632	3,277	2,223	475	725	3,423
Stage IV	1,428	177	761	2,366	1,428	207	892	2,527
Missing	131	10	59	200	131	9	47	187
All cases	7,363	1,156	1,919	10,438	7,363	1,280	2,175	10,818
	Scenario 5: Modelled proportion of treated patients; Constant incidence rate; Constant survival rates				Scenario 6: Modelled proportion of treated patients; Constant incidence rate; Improving survival rates
Stage at diagnosis	Newly diagnosed patients	Non-terminal cancer recurrence	Terminal cancer recurrence	Total	Newly diagnosed patients	Non-terminal cancer recurrence	Terminal cancer recurrence	Total
Stage I+II	3,613	560	562	4,735	3,613	602	613	4,828
Stage III	1,831	362	628	2,821	1,831	415	727	2,973
Stage IV	1,675	206	890	2,771	1,675	241	1,038	2,954
Missing	122	9	121	252	122	7	92	221
All cases	7,241	1,137	2,201	10,579	7,241	1,265	2,470	10,976
	Scenario 7: Modelled proportion of treated patients; Modelled incidence rate; Constant survival rates				Scenario 8: Modelled proportion of treated patients; Modelled incidence rate; Improving survival rates
Stage at diagnosis	Newly diagnosed patients	Non-terminal cancer recurrence	Terminal cancer recurrence	Total	Newly diagnosed patients	Non-terminal cancer recurrence	Terminal cancer recurrence	Total
Stage I+II	3,542	544	549	4,635	3,542	583	599	4,724
Stage III	2,285	429	734	3,448	2,285	484	844	3,613
Stage IV	1,697	203	887	2,787	1,697	236	1,036	2,969
Missing	72	5	71	148	72	5	57	134
All cases	7,596	1,181	2,241	11,018	7,596	1,308	2,536	11,440